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Oocyte maturations oocytes with cholesterol-depleting methyl-β-cyclodextrin (MeβCD) stimulates
phosphorylation of mitogen-activated protein kinase (MAPK) and oocyte maturation, as reported previously
[Sadler, S.E., Jacobs, N.D., 2004. Stimulation of Xenopus laevis oocyte maturation by methyl-β-cyclodextrin.
Biol. Reprod. 70, 1685–1692.]. Here we report that treatment of oocytes with MeβCD increased levels of
immunodetectable 39-kDa mos protein. The protein synthesis inhibitor, cycloheximide, blocked the
appearance of Mos, blocked MeβCD-stimulated phosphorylation of MAPK, and inhibited MeβCD-induced
oocyte maturation. These observations suggest that MeβCD activates the progesterone-signaling pathway.
Chemical inhibition of steroid synthesis and mechanical removal of follicle cells were used to verify that
MeβCD acts at the level of the oocyte and does not require production of steroid by surrounding follicle cells.
Cortical Gαs is contained in low-density membrane; and treatment of oocytes with progesterone or MeβCD
reduced immunodetectable levels of Gαs protein in cortices and increased internal levels of 45-kDa Gαs in
cortical-free extracts. Dose-dependent increases in internal Gαs after treatment of oocytes with progesterone
correlated with the steroid-induced maturation response, and the increase in internal Gαs after hormone
treatment was comparable to the decrease in cortical Gαs. These results are consistent with a model in which
release of Gαs from the plasma membrane is involved in activation of the progesterone-signaling pathway
that leads to amphibian oocyte maturation.
© 2008 Elsevier Inc. All rights reserved.Introduction
Amphibian oocytes, physiologically arrested at the G2/M border
of the ﬁrst meiotic division, can be stimulated in vitro to undergo cell
division (also called germinal vesicle breakdown (GVBD) or oocyte
maturation) by treatment with progesterone (Masui, 1967) or insulin
or insulin-like growth factor-1 (IGF-1) (El-Etr et al., 1979; Maller and
Koontz, 1981). In the signal transduction pathways that trigger
oocyte maturation, a transient, requisite decrease in oocyte cAMP
(Maller et al., 1979) is supported by inhibition of adenylyl cyclase and
stimulation of phosphodiesterase. Inhibition of Xenopus oocyte
adenylyl cyclase by progesterone (Finidori-Lepicard et al., 1981;
Jordana et al., 1981; Sadler and Maller, 1981) is not mediated by Gαi
(Sadler et al., 1984). Instead, progesterone somehow inhibits oocyte
adenylyl cyclase through Gαs by slowing guanine nucleotide
exchange, as evidenced by a slowing of hysteretic activation of
enzyme activity (Sadler and Maller, 1983; Jordana et al., 1984). Gαs isS; University of Denver, PROF
earch Assistantship, University
l rights reserved.involved in maintenance of meiotic prophase arrest in oocytes of
many vertebrate species. Microinjection of inhibitory anti-Gαs
antibody is sufﬁcient to stimulate meiotic maturation in amphibian
(Gallo et al., 1995), mouse (Mehlmann et al., 2002) and zebraﬁsh
oocytes (Kalinowski et al., 2004). And microinjection of a dominant
negative Gαs construct is sufﬁcient to induce meiotic maturation in
mouse and Xenopus oocytes (Kalinowski et al., 2004).
Progesterone-induced amphibian oocytematuration requires synthesis
of new proteins, including the c-mos protooncogene product (for reviews
see Gebauer and Richter, 1997; Karaiskou et al., 2001; Castro et al., 2001;
Tunquist and Maller, 2003), and treatment of oocytes with cycloheximide
blocks progesterone-induced GVBD (Morrill et al., 1975). De novo
synthesis of 39-kDa Mos is regulated at the level of translation by
cytoplasmic polyadenylation of c-mos mRNA soon after hormone
treatment. Newly synthesized Mos protein is evident in progesterone-
treated cells at GBVD50 (the time when 50% of oocytes have undergone
germinal vesicle breakdown), and Mos is subsequently stabilized by
phosphorylation (Roy et al., 1996; Sagata, 1997). Mos is a serine-threonine
protein kinase that phosphorylates and activates the mitogen-activated
protein kinase (MAPK) kinase, MEK1, that in turn phosphorylates and
activates MAPK. Through activation of kinase cascades, Mos and other
newly synthesized proteins apparently converge at the level of the M-
phase promoting factor, MPF, a complex between cyclin B and the cyclin-
dependent kinase, Cdc2.
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and adenylyl cyclase may interact dynamically within membrane
rafts or caveolae (for reviews see Smart et al., 1999; Anderson and
Jacobson, 2002; Razani et al., 2002; Pike, 2004). In Xenopus eggs, low-
density membrane microdomains apparently act as organizing
centers for tyrosine kinase signaling in sperm-egg interaction
(Mahbub Hasan et al., 2007) and fertilization (Luria et al., 2002;
Sato et al., 2002). Low-density membrane fractions from Xenopus
oocytes share a number of biochemical characteristics with choles-
terol-rich membrane microdomains in mammalian cells, and low-
density membrane prepared from oocyte cortices contains a
caveolin-like protein (Sadler, 2001). Membrane cholesterol and low-
density membrane microdomains play a role in maintaining meiotic
arrest, as evidenced by the ability of cholesterol-depleting drug,
methyl-β-cyclodextrin (MeβCD), to induce amphibian oocyte
maturation. Treatment of oocytes with MeβCD leads to phosphoryla-
tion of mitogen-activated protein kinase (MAPK), chromosome
condensation, spindle formation and germinal vesicle breakdown;
and the cell division response correlates with the ability of MeβCD to
deplete radiolabeled cholesterol previously loaded into oocytes
(Sadler and Jacobs, 2004).
The experiments reported here were designed to test if treatment
of oocytes with MeβCD might lead to other biochemical changes that
are indicative of the progesterone-signaling pathway. Anti-Mos
antibody was used to detect 39-kDa Mos protein in oocyte extracts
following treatment with MeβCD. The protein synthesis inhibitor,
cycloheximide, was tested for its ability to inhibit MeβCD-stimulated
phosphorylation of oocyte MAPK, production of Mos, and GVBD.
Additional experiments were performed to verify that the MeβCD
response was at the level of the oocyte and did not require production
of steroid by surrounding follicle cells. Finally, MeβCD was compared
to progesterone for its ability to affect the distribution of Gαs between
the cell surface and cortical-free extracts. The results demonstrate that
treatment of amphibian oocytes with the cholesterol-depleting drug,
MeβCD, stimulates the oocyte Mos/MAPK progesterone-signaling
pathway and that the progesterone pathway involves release of Gαs
from the oocyte surface.
Materials and methods
Animals and oocyte isolation
Mature Xenopus laevis females (Xenopus I, Dexter, MI) were
housed in aquatic tanks at 16 °C, fed ground beef twice weekly, and
maintained on daily cycles of 14 h light and 10 h dark. The protocol
for use of vertebrate animals was approved by the University of
Denver Animal Care and Use Committee and complies with the Public
Health Service Policy on Humane Care and Use of Laboratory
Animals. Donor frogs were primed by injection of 35 IU of pregnant
mare's serum gonadotropin (Calbiochem, La Jolla, CA) into the dorsal
lymph sac 3–5 days before surgical removal of ovarian fragments.
Before surgery, frogs were anesthetized by partial immersion in a
solution containing 0.12% tricaine (3-aminobenzoic acid ethyl ester;
Sigma, St. Louis, MO) in 25 mM Hepes (Calbiochem), pH 7.0. Pieces of
ovary were surgically removed and stored at room temperature in
oocyte Ringers (83 mM NaCl, 1 mM KCl, 1 mM MgCl2, 0.5 mM CaCl2,
10 mM Hepes, pH 7.9). Large oocytes, 1.1–1.2 mm diameter, were man-
ually dissected from surrounding connective tissue and thecal cell layers
using watchmaker's forceps under a stereomicroscope and stored in
oocyte Ringers at room temperature. These oocytes retained surround-
ing follicle cells and are referred to below as dissected oocytes.
Hormone/drug treatments and monitoring of oocyte maturation
Hormone and drug treatments were done the same day that
oocytes were isolated. Groups of oocytes were incubated in theindicated volumes of oocyte Ringers-HCO3 (73 mM NaCl, 10 mM
NaHCO3, 1 mMMgCl2, 0.5 mM CaCl2, 1 mM KCl, 25 mMHepes, pH 7.9)
in the absence or presence of indicated concentrations of progester-
one (Calbiochem; diluted into oocyte Ringers-HCO3 from a 0.5 mg/ml
stock solution in ethanol), 50 mM MeβCD (Sigma), or 50 IU human
chorionic gonadotropin (hCG) (Sigma). GVBD was quantiﬁed by
appearance of white spots in unblemished oocytes and veriﬁed by
ﬁxing the oocytes for 30 min by addition of trichloroacetic acid to a
ﬁnal concentration of 2%, opening the oocytes with watchmaker's
forceps under the stereomicroscope, and determining the presence or
absence of an intact nucleus (germinal vesicle) by visual inspection.
Oocyte maturation results are expressed as the percentage of oocytes
that underwent germinal vesicle breakdown (% GVBD) as a function of
drug treatments.
Removal of follicle cells
To remove follicle cells, dissected oocytes were rolled on abrasive
paper using a methodmodiﬁed from Sheng et al. (2005). After oocytes
were rinsed twice by transfer through Ca+2/Mg+2-free buffer
(82.5 mM NaCl, 2.5 mM KCl, 1 mM Na2HPO4, 5 mM Hepes, pH 7.8),
groups of 100–120 oocytes were rolled at 80 rpm for 2–3 h at room
temperature in 8-ml volumes of Ca+2/Mg+2-free buffer in small glass
Petri dishes that were lined with ﬁne abrasive paper (0.05 μm alumina
ﬁlm; Fiberlap Technologies, Tucson, AZ) using a MaxQ Mini4000
(Barnstead International, Dubuque, IA). After removal of follicle cells,
oocytes are referred to below as defolliculated oocytes.
Immunoblot detection of phospho-MAPK, ERK1/2, Mos, and internal Gαs
Phospho-MAPK, ERK1/2, Mos, and internal Gαs were detected by
protein immunoblotting of cortical-free extracts prepared by a
method modiﬁed from Haccard et al. (1995). Oocytes were incubated
in oocyte Ringers-HCO3 in the presence of indicated concentrations of
progesterone or 50 mM MeβCD. At indicated time points, randomly
selected subsets of unblemished oocytes were removed from
treatment groups, washed by transfer through two dishes of Ring-
ers-HCO3, and dropped into 1.5-ml conical tubes. The Ringers-HCO3
was removed, and the cells were homogenized in 10X volume [either
6 oocytes in 60 μl, 12 oocytes in 120 μl, or 20 oocytes in 200 μl] of ice-
cold homogenization buffer (80 mM β-glycerophosphate, pH 7.4,
20 mM EGTA, 15 mM MgCl2, 1 mM dithiothreitol, 100 μM sodium-
orthovanadate, 10 mM NaF, 10 μg/ml leupeptin, 1 mM phenylmethyl-
sulfonyl ﬂuoride (PMSF), 10 μg/ml aprotinin) using a plastic pestle.
After centrifugation (10,000 ×g for 5 min at 4 °C), a portion of clear,
cortical-free supernatant was removed, mixed with an equal volume
of 2× electrophoresis sample buffer (140 mM Tris–HCl, pH 6.8, 22.3%
glycerol, 0.003% bromophenol blue, 6% SDS, 10% β-mercaptoethanol),
and heated in a boiling water bath for 5 min. Proteins contained in
12-μl volumes of the ﬁnal extracts were resolved by SDS-PAGE (12.5%
acrylamide), and electroblot transferred to polyvinylidene ﬂuoride
membrane (Immobilon-P, Millipore, Bedford, MA) using a Bio-Rad
Trans-blot SD semi-dry transfer cell. After blocking with I-Block
(Tropix, Bedford, MA), phosphorylated MAPK was detected using 1-h
incubation in 1:2500 of rabbit polyclonal anti-active MAPK (V8031;
Promega, Madison, WI) as primary antibody. Mos protein was
detected using 1-h incubation in 1:200 of rabbit polyclonal anti-
Mosxe (C237; Santa Cruz Biotechnology, Santa Cruz, CA) or overnight
incubation in 1:1000 dilution of rabbit polyclonal anti-Mos (a gift
from Joan Ruderman, Harvard University, custom made to an N-
terminus sequence of Xenopus Mos (Lieberman and Ruderman,
2004)). Internal Gαs was detected using 1-h incubation in 1:500
dilution of rabbit polyclonal anti-Gαs (K-20) (sc-823; Santa Cruz
Biotechnology, Santa Cruz, CA) or 1-h incubation in 1:2000 of RM
anti-Gαs (a gift from Laurinda Jaffe, University of Connecticut Health
Center (Gallo et al., 1995)). In all cases 1:10,000 goat anti-rabbit
Fig. 1. Cycloheximide blocks MAPK phosphorylation and GVBD in response to MeβCD.
Groups of 125 oocytes were incubated for 1 h in 2-ml volumes of oocyte Ringers-HCO3
in the absence or presence of 20 μM cycloheximide (CHX). Then, as indicated, 3 μM
progesterone was added (Prog), or oocytes were transferred to 50 mM MeβCD or
50 mM MeβCD plus 20 μM CHX in 2-ml volumes of oocyte Ringers-HCO3. Control cells
were incubated in oocyte Ringers-HCO3. Cells were gently swirled at room
temperature. In these experiments, GVBD50 was observed ~2–3 h after progesterone
treatment and ~5–6 h after MeβCD treatment. Upper panel — At 2-h intervals,
randomly selected subsets of 6 oocytes each were removed from treatment groups,
homogenized, and extracts were prepared and immunoblots were analyzed for MAPK
phosphorylation (pMAPK) and then stripped and re-probed for total MAPK (ERK1/2)
by protein immunoblotting, as described in Materials and methods. Lower panel —
When white spot formation indicated that oocyte maturation in response to hormone
or drug treatment was complete (after 8–18 h in different experiments), oocytes were
acid-ﬁxed and dissected to quantify the GVBD response. (n=4 experiments, mean±SE)
⁎, signiﬁcantly less than MeβCD alone, p≤0.05; ⁎⁎⁎, signiﬁcantly less than
progesterone alone, p≤0.001.
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antibody. Chemiluminescent detection was accomplished using CDP-
Star (Tropix) with exposure to FujiFilm Super RX ﬁlm. After detection
of phospho-MAPK, membranes were stripped by rotating in 10-ml
volumes of solution containing 62.5 mM Tris–HCl, pH 6.8, 2% SDS, and
100 mM β-mercaptoethanol at 70° C for 30 min, then washed three
times (5 min each) in Tris-buffered saline (150 mM NaCl, 10 mM Tris–
HCl, pH 7.5), and re-blocked. Total MAPK was then detected using
1:2500 rabbit polyclonal anti-ERK1/2 (V114A; Promega) as primary
antibody and alkaline phosphatase-conjugated secondary antibody
with chemiluminescent detection. Apparent molecular weights of
immunoblot bands were determined by comparison to pre-stained
low molecular weight standards (161-0305; BioRad, Hercules, CA).
Immunoblot detection of surface-associated cortical Gαs
Oocyte cortices were peeled from oocytes using a manual method
described previously (Sadler and Maller, 1981). After indicated
treatments, oocytes were transferred to a small Petri dish containing
ice-cold isolation buffer (10 mM NaCl, 10 mM HEPES, pH 7.9), pierced
and opened with watchmaker's forceps under a stereomicroscope,
and ﬂattened with membrane up. After soaking on ice for 10–15 min,
cortices (plasma membrane/vitelline envelope complexes with asso-
ciated follicle cells) were gently peeled away from the bulk of
intracellular content, collected using a Pasteur pipet, and transferred
to plastic v-tubes in groups of 10. Membrane pellets were collected by
centrifugation (10,000 ×g for 5 min at 4 °C) and analyzed by SDS-PAGE
(12.5% polyacrylamide) and protein immunoblotting. Cortical Gαs was
detected with 1-hr incubation of the membrane in 1:1000 rabbit
polyclonal anti-Gαs-subunit, C-terminal (385–394) (371732, Calbio-
chem) or in 1:2000 RM anti-Gαs as primary antibody.
Sucrose gradient resolution of low- and high-density
membrane fractions
Cortices prepared from groups of 300 manually dissected oocytes
were used as starting material for resolution of low-density and high-
density membrane fractions using a detergent-free method modiﬁed
from Song et al. (1996), as described previously (Sadler, 2001). Low-
density membrane was collected from the interface of the 5% and 35%
sucrose layers, and high-density membrane was collected from the
interface of the 35% and 45% sucrose layers.
Measurement of relative changes in cortical and internal levels of Gαs
Levels of Gαs were analyzed between treatment groups on each
immunoblot by linear scanning of lanes on ﬁlm images using a
Beckman DU-64 Spectrophotometer. Photocopies of absorbance
proﬁles were analyzed by a simpliﬁed area-under-the-curve analysis
in which peaks on paper printouts corresponding to the 45-kDa
immunoblot band were cut out and weighed on an analytical balance,
and peak weights were compared. As described in each ﬁgure, relative
changes in Gαs were compared on each immunoblot after normalizing
control values and adjusting treatment groups relative to control or by
expressing observed changes as percent maximum increases relative
to control.
Data presentation
Numeric datawere plotted using SigmaPlot 8.0 (SPSS, Inc., Chicago,
IL). Figures are representative of reproducible experiments using
oocytes from different donor females. Figure legends describe how
error bars were generated using data combined from different
numbers of samples or experiments (indicated by n values).
Differences between treatment groups were compared using the
Student t-test.Results and discussion
Protein synthesis is required for MeβCD action
MeβCD was observed previously to accelerate progesterone-
induced Xenopus oocyte maturation and induce oocyte maturation;
the MeβCD-induced oocyte maturation response is slower than the
progesterone response, corresponds to a slower time course of MAPK
phosphorylation, and correlates with the ability of MeβCD to deplete
oocytes of previously loaded radiolabeled cholesterol (Sadler and
Jacobs, 2004). The current study was designed to further characterize
the action of MeβCD by comparison to hallmarks of the progesterone-
signaling pathway — requisite protein synthesis and synthesis of Mos
protein. The protein synthesis inhibitor, cycloheximide, was used to
test if protein synthesis is required for MeβCD-induced oocyte
responses. As shown in Fig. 1 (upper panel), treatment of oocytes
with progesterone for 2 h was sufﬁcient to stimulate phosphorylation
of MAPK, and pretreatment of oocytes with cycloheximide blocked the
progesterone-stimulated increase in phospho-MAPK. Treatment of
oocytes with MeβCD also stimulates phosphorylation of MAPK,
although on a slower time course (Sadler and Jacobs, 2004; Fig. 1
(middle panel)), and pretreatment of oocytes with cycloheximide
blocked the increase in phospho-MAPK in response to MeβCD (Fig. 1,
Fig. 2. Progesterone- and MeβCD-stimulated increases in oocyte 39-kDa Mos are
inhibited by cycloheximide. Groups of 200 oocytes were incubated for 1 h in 2-ml
volumes of oocyte Ringers-HCO3 in the absence or presence of 20μM cycloheximide
(CHX) before addition of 3 μM progesterone (Prog) or transfer to 2-ml volumes of
50 mM MeβCD without or with 20 μM CHX. Treatment groups were gently swirled at
room temperature. At indicated times, randomly selected subsets of 6 oocytes (Mosxe)
or 20 oocytes (Mos) were removed, homogenized, and extracts were prepared and
analyzed for Mos by protein immunoblotting, as described in Materials and methods.
Each immunoblot panel shows results from separate representative experiments using
oocytes from different frogs. Mos was detected in 6 different experiments after
treatment of oocytes with progesterone or MeβCD. Inhibition of Mos synthesis with
cycloheximide was measured in three different experiments using anti-Mos antibody
and 24-h time points, and 39-kDa band densities above baseline were determined by
linear scanning of ﬁlms and compared (lower panel) after normalizing the heaviest
band in each blot to 100. Average relative band densities in these three experiments are
presented in the bar graph (n=3 experiments, mean±SE).
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ERK1/2 to detect total levels of MAPK irrespective of phosphorylation,
comparable band intensities veriﬁed that the differences detectedwith
anti-pMAPK antibody were indicative of increased levels of phospho-
MAPK and were not artifacts of gel lane loading. Cycloheximide also
was tested for its ability to inhibit progesterone- and MeβCD-
stimulated oocyte maturation (Fig. 1, lower panel). In a series of four
experiments, oocytes treatedwith progesterone displayed 100%GVBD,
and pretreatment of oocytes with cycloheximide completely blocked
the response to progesterone. This recapitulates the observations of
others (Morrill et al., 1975) and demonstrates the requirement for
protein synthesis in progesterone-induced amphibian oocyte matura-
tion. TheMeβCD-induced cell division response averaged 64%±16, and
pretreatment of oocyteswith cycloheximide signiﬁcantly inhibited the
MeβCD-induced oocyte maturation response to 12%±5. This indicates
a requirement for de novo protein synthesis in the MeβCD-stimulated
oocyte response, similar to the requirement for protein synthesis for
progesterone-induced oocyte maturation.
Treatment of oocytes with MeβCD leads to synthesis of Mos
The c-Mos/MAPK progesterone pathway involves de novo synth-
esis of Mos protein (Tunquist and Maller, 2003). Immunodetectable
Mos appears in oocyte extracts at GVBD50 – the time point after
progesterone treatment when 50% of oocytes display GVBD (Roy et al.,
1996; Sagata, 1997), and Mos levels remain elevated until fertilization
or oocyte activation. Anti-Mos antibody was used to test for Mos in
oocytes after treatment with MeβCD. Both commercial anti-Mosxe
antibody (C237; Santa Cruz Biotechnology, Santa Cruz, Ca) and custom
made anti-Mos (provided by Joan Ruderman, Harvard University)
were used to detect Mos protein in oocyte extracts. Fig. 2 shows
representative immunoblots for Mos using oocytes from three
different donor animals. The 39-kDa Mos protein was typically
detected after 3 h of progesterone treatment (Fig. 2A) when oocytes
displayed approximately 50% GVBD (data not shown). In MeβCD-
treated oocytes Mos was detected after 6 h (Fig. 2A), corresponding to
the typical GVBD50 for cyclodextrin-treated oocytes (Sadler and
Jacobs, 2004). Cycloheximide was used to test whether de novo
protein synthesis is required for appearance of the 39-kDa Mos band
(Fig. 2B). As with progesterone treatment, synthesis of Mos following
treatment of oocytes with MeβCD was blocked by cycloheximide.
More extensive analysis of the biochemical interplay between Mos
and MAPK in response to MeβCD is beyond the scope of this study.
Nonetheless, Figs. 1 and 2 indicate that MeβCD stimulates synthesis of
oocyte Mos and that protein synthesis is required for the MeβCD-
induced oocyte maturation response, consistent with activation of the
progesterone-signaling pathway by MeβCD.
MeβCD acts at the level of the oocyte
After manual dissection from ovarian fragments with watch-
maker's forceps, Xenopus oocytes are surrounded by a tightly attached
layer of follicle cells. The functional presence of surrounding follicle
cells is indicated by in vitro responsiveness of dissected oocytes to
gonadotropin. Oocyte maturation in response to human chorionic
gonadotropin (hCG) depends upon synthesis and release of steroid
hormones, including progesterone, from ovarian follicle cells (Snyder
and Schuetz, 1973; Mulner and Ozon, 1981). When steroid synthesis is
inhibited or the follicle cell layer has been removed, responsiveness to
gonadotropin is lost due to removal of the secondary source of steroid
hormone. It was conceivable that stimulation of MAPK phosphoryla-
tion and oocyte maturation by MeβCD could have resulted from
increased synthesis of steroid hormone by follicle cells. Over the years,
proteolytic enzyme treatments have been used by various labs to
damage and/or remove follicle cells from manually dissected oocytes.
We reported previously that treatment of oocytes with pronase didnot block the MeβCD-induced oocyte maturation response, but rather
accelerated thematuration response to both progesterone andMeβCD
(Sadler and Jacobs, 2004). And we used that evidence to support
MeβCD acting at the level of the oocyte. Here, we extended the
previous studies to include a more rigorous veriﬁcation that MeβCD
acts at the level of the oocyte and does not require follicle cells. Two
experimental approaches were used: pharmacological inhibition of
progesterone synthesis and mechanical removal of follicle cells.
Steroid synthesis inhibitors, including cyanoketone and aminoglu-
tethimide (Snyder and Schuetz, 1973; Mulner and Ozon, 1981) have
been used to investigate requirements for steroid synthesis in
amphibian oocytes. These drugs inhibit desmolase, the enzyme that
catalyzes cleavage of the sterol side chain thereby converting
cholesterol to pregnenolone, an intermediate in the progesterone
synthesis pathway. Aminoglutethimide is commercially available
(Sigma A-9657), and it proved relatively non-toxic to the oocytes if
we re-adjusted pH to 7.8 after its addition to oocyte Ringers-HCO3. In a
series of time course studies, an 8- to 10-h preincubation of manually
dissected oocytes in 1 mM aminoglutethimide was determined to be
sufﬁcient to inhibit hCG-stimulated oocyte maturation (data not
shown). Using this preincubation protocol, aminoglutethimide was
used to test whether steroid synthesis is required in the oocyte
response to MeβCD (Fig. 3). In three experiments, untreated control
groups of oocytes displayed no spontaneous maturation, and hCG
stimulated an average of 73%±8 GVBD. Pretreatment of companion
groups of cells with aminoglutethimide reduced the hCG-induced
GVBD response to 22%±5. This is consistent with previous reports in
which steroid synthesis inhibitors have been observed to block
Fig. 3. The steroid synthesis inhibitor, aminoglutethimide, does not block oocyte
maturation stimulated by MeβCD. Groups of 100 oocytes were incubated for 8–10 h
in 2-ml volumes of oocyte Ringers-HCO3 in the absence (open bars) or presence
(hatched bars) of 1 mM aminoglutethimide, pH 7.8, before addition of 50 IU/ml of
hCG, 3 μM progesterone (Prog) or transfer of oocytes to 2-ml volumes of oocyte
Ringers-HCO3 containing aminoglutethimide and 50 mM MeβCD. Groups were then
gently swirled at room temperature overnight (for 12–16 h), and GVBD was
quantiﬁed by dissection of oocytes after acid-ﬁxation as described in Materials and
methods. Control cells were incubated in oocyte Ringers-HCO3. (n=3 experiments,
mean±SE) ⁎⁎, signiﬁcantly less than hCG alone, p≤0.01.
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Ozon, 1981). Aminoglutethimide did not signiﬁcantly inhibit MeβCD-
stimulated oocyte maturation, suggesting that steroid synthesis is not
required for the MeβCD response; and, as predicted, aminoglutethi-
mide had no effect on the progesterone response (Fig. 3). Moreover,
the 100% GVBD response to progesterone after treatment of oocytes
with aminoglutethimide demonstrates that the steroid synthesis
inhibitor was not toxic to the cells. But, while these data support an
action of MeβCD that is independent of steroid synthesis by follicleFig. 4. Follicle cells are not required for phosphorylation of oocyte MAPK or GVBD
induced by MeβCD. After manual dissection from ovarian fragments, paired groups of
125 oocytes were incubated in oocyte Ringers (+Follicle cells) or rolled on abrasive
paper in Ca+2/Mg+2-free buffer to remove follicle cells (−Follicle cells). Upper panel —
Groups of oocytes were treated with 50 mM MeβCD in oocyte Ringers-HCO3. At
indicated times, randomly selected subsets of 6 oocytes were removed, homogenized,
and extracts were prepared and analyzed for phosphorylated MAPK (pMAPK) and total
MAPK (ERK1/2) by protein immunoblotting, as described in Materials and methods.
Lower panel — Companion groups of 40–50 oocytes were incubated in oocyte Ringers-
HCO3 (Control; n=4, mean±SE), treated with 50 IU/ml of human chorionic
gonadotropin (hCG; n=4, mean±SE), 50 mM MeβCD (n=3, mean±SE), or 3 μM
progesterone (Prog; n=2, average±half-range). After incubation overnight (12–18 h) at
room temperature with gentle swirling, oocytes were acid-ﬁxed, and unblemished cells
were dissected to quantify GVBD responses. ⁎⁎, signiﬁcantly less than hCG alone,
p≤0.01.cells, we were not satisﬁed with the variability in MeβCD responsive-
ness between experiments after aminoglutethimide treatment (indi-
cated by the wide error bar). So, additional experiments were
performed in which follicle cells were mechanically removed from
dissected oocytes.
Liu's group developed amethod for removing follicle cells from the
surface of manually dissected Xenopus oocytes by rolling the cells on
ﬁne abrasive paper in Ca+2-free buffer (Sheng et al., 2005). We
modiﬁed the method to use Ca+2/Mg+2-free buffer, because in our
hands omission of magnesium salts from the buffer recipe resulted in
more complete removal of follicle cells. As shown in Fig. 4 (lower
panel), removal of follicle cells inhibited the hCG response, but had no
signiﬁcant effect on the progesterone response. This reproduces the
work of Sheng et al. (2005) and veriﬁes the effectiveness of follicle cell
removal. Removal of follicle cells did not affect the ability of MeβCD to
stimulate oocyte maturation. In oocytes with follicle cells attached,
treatment with MeβCD induced an average of 76%±23 GVBD. After
removal of follicle cells, the oocyte response toMeβCDwas unchanged
(79%±10 (Fig. 4, lower panel)). Phosphorylation of MAPK was also
tested as a biochemical indicator of oocyte responsiveness to MeβCD
(Fig. 4, upper panel). Removal of follicle cells did not block the ability of
MeβCD to stimulate MAPK phosphorylation. Instead, phospho-MAPK
was detected in MeβCD-treated defolliculated oocytes more quickly
than in dissected oocytes (with follicle cells still attached). As before,
immunoblotswere stripped and retestedwith anti-ERK1/2 antibody to
verify comparable loading of gel lanes. We also observed that
defolliculated oocytes displayed a more rapid MeβCD-induced GVBD
response than oocytes with follicle cells attached (data not shown),
suggesting that removal of follicle cells offers better exposure of the
oocyte surface to cholesterol-depleting drug. These results support a
direct action of MeβCD on the oocyte to stimulate phosphorylation of
MAPK and germinal vesicle breakdown; follicle cells and steroid
hormone synthesis are not required for the MeβCD response.
Progesterone and MeβCD decrease levels of cortical Gαs
We took advantage of the stabilizing effect of the amphibian
oocyte vitelline envelope to manually isolate cortices (plasma
membrane-vitelline envelope complexes) and to analyze associatedFig. 5. Cortical 45-kDa Gαs is contained in low-density membrane and is reduced
after treatment of oocytes with progesterone or MeβCD. Left panel — Cortical samples
were collected from 10 oocytes (lane 1) or cortices were isolated from 300 oocytes and
used as starting material for resolution of low-density membrane (LDM) and high-
density membrane (HDM) fractions using detergent-free sucrose gradient centrifuga-
tion (lanes 2 and 3, respectively). Proteins were resolved by SDS-PAGE (12.5% poly-
acrylamide) and immunoblot detected using anti-Gαs from Calbiochem, as described in
Materials and methods. Right panel — In multiple experiments using oocytes from
different frogs, relative levels of cortical Gαs were compared between oocytes
incubated in the absence (Control; n=9, mean±SE) or presence of 3 μM progesterone
(Prog; n=9, mean±SE) or 50 mM MeβCD (n=7, mean±SE). After 2 h, groups of 10
unblemished oocytes were removed from each treatment group, cortices were isolated,
and levels of surface-associated 45-kDa Gαs were determined by protein immunoblot-
ting using anti-Gαs (Calbiochem). In each experiment, relative band densities in gel
lanes were measured, control band densities were normalized to 100, and relative
hormone and drug effects were determined relative to control. These normalized
values were averaged between experiments. ⁎, signiﬁcantly less than Control, p≤0.05;
⁎⁎, signiﬁcantly less than Control, p≤0.01.
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preparation was used previously to measure progesterone-induced
inhibition of oocyte adenylyl cyclase (Sadler and Maller, 1981; Sadler
and Maller, 1983). Calbiochem anti-Gαs antibody detected a single,
sharp 45-kDa band in isolated cortices (Fig. 5, left panel, lane 1). In
cortices prepared from unstimulated Xenopus oocytes Gαs was
contained exclusively in cholesterol-rich, low-density membrane
(Fig. 5, left panel, lane 2). Treatment of oocytes with progesterone or
MeβCD reduced the apparent amounts of 45-kDa Gαs detected in
oocyte cortices with the Calbiochem anti-Gαs antibody (Fig. 5, right
panel). Time course studies demonstrated that drug- or hormone-
induced decreases in cortical Gαs were maximal after 2 h (data not
shown), so 2-h incubations were used. Data between experiments
were combined after normalizing the 45-kDa band densities in
immunoblot lanes containing cortices from untreated oocytes to 100
and calculating Gαs band intensities relative to control for treatment
groups in each experiment. In this way, changes within experiments
could be compared between experiments. Progesterone treatment
decreased cortical Gαs by 24%±9 after 2 h, and MeβCD decreased
cortical Gαs by 67%±3 (Fig. 5, right panel).
Dose-response and semi-quantitative analysis of Gαs translocation
Measurement of concomitant increases in internal Gαs after
treatment of oocytes with hormone proved to be a challenge. In ourFig. 6. Analysis of progesterone-induced changes in Gαs distribution between cortex a
increase in internal Gαs and GVBD. Left panel — A representative blot of cortical-free extr
protein is shown. The 45-kDa band is indicated by the arrow to the left of the blot. Appar
Right panel— Oocytes were incubated at room temperature in 2-ml volumes of oocyte Ring
2 h, groups of 12 oocytes were removed and soluble extracts were prepared. Relative
immunoblotting using Santa Cruz anti-Gαs as primary antibody, expressed as percentag
nion sets of cells. (n=3 experiments, mean±SE). (B) Semi-quantitative comparison of proges
Immunoblot detection of Gαs in cortical samples and cortical-free extract using RM anti-G
preparation (lane 1), a 0.5 oocyte equivalent of cortical-free extract (lane 2), or cortices coll
cortical and increase in internal 45-kDa Gαs after incubation of oocytes in the absence (Co
immunoblot ﬁlm was used to compare relative changes in 45-kDa Gαs bands (arbitrary uni
Gels were loaded with 0.5 oocyte equivalents of cortical samples collected from sets of 10
and methods. Extended exposure of the immunoblots to ﬁlm revealed subtle but measura
linear spectrophotometric scanning. The bar graph shows average values for triplicate sam
results. (n=3; mean±SE); ⁎⁎, signiﬁcantly less than control for cortical samples or signiﬁcahands, the Calbiochem anti-Gαs antibody that was used to detect
changes in cortical Gαs (Fig. 5) did not cleanly detect internal 45-kDa
Gαs in cortical-free extracts or immunoprecipitates of cortical-free
extracts after treatment of oocytes with progesterone or MeβCD (data
not shown). But we were able to detect a 45-kDa immunoblot band in
cortical-free extracts using a Santa Cruz anti-Gαs antibody (K-20) (Fig.
6A). In addition to the 45-kDa band, the Santa Cruz antibody also
detected prominent lower molecular weight (34- and 36-kDa) bands
and higher molecular weight bands (52-, 78- and 200-kDa). The 45-
kDa band that was detected in cortical-free extracts with the Santa
Cruz antibody co-migrated on one-dimensional gel electrophoresis
with the cortical 45-kDa band detected with the Calbiochem antibody,
as determined by sequential immunodetection of combined cortical
and extract samples (data not shown), so we assume that both
antibodies detected the same 45-kDa protein.
After treatment of oocytes with progesterone (Fig. 6A) or MeβCD
(data not shown), immunodetectable 45-kDa Gαs was increased in
cortical-free extracts, but the other immunoblot bands did not
increase in intensity. In an effort to substantiate the physiological
relevance of observed changes in Gαs, dose-response analysis of
progesterone-stimulated increases in internal G protein was com-
pared to the dose-response for progesterone-induced GVBD (Fig. 6A,
right panel). Results in each of three experiments were expressed as
percentage of the maximum observed increase in internal Gαs and
averaged to generate the dose-response curve. GVBD responses werend cortical-free extract. (A) Dose-response analysis of the progesterone-stimulated
act using Santa Cruz anti-Gαs as primary antibody for immunodetection of 45-kDa G
ent molecular weights for additional bands are indicated by the numbers to the right.
ers-HCO3 in the absence or presence of indicated concentrations of progesterone. After
levels of internal 45-kDa Gαs (○) in each experiment were determined by protein
e maximum increase, and compared to the next-day GVBD response (●) in compa-
terone-stimulated changes in cortical and cortical-free extract 45-kDa Gαs. Left panel —
αs as primary antibody. Lanes were loaded with a 0.5 oocyte equivalent of a cortical
ected from 10 oocytes (lane 3). Right panel — Comparison of the measured decrease in
ntrol) or presence of 3 μM progesterone (Prog) for 2 h. Linear scanning of lanes on the
ts) in cortical samples (Cortical) and cortical-free extracts (Internal) to control samples.
oocytes or cortical-free extracts prepared from 20 oocytes, as described in Materials
ble changes in 45-kDa band intensities, and these band intensities were quantiﬁed by
ples in a single experiment that is representative of three experiments with similar
ntly greater than control for internal (cortical-free) extracts; p≤0.05.
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directly correlated with the observed, dose-dependent increase in
internal Gαs. Apparent EC50 values – concentrations that elicited 50%
of the observed maximal responses – were on the order of 15 nM
progesterone for both the increase in internal Gαs and the GVBD
response. This overlap of dose-response curves supports physiological
signiﬁcance for the progesterone-stimulated increase in internal 45-
kDa Gαs.
The observed difference in the abilities of the commercial
antibodies to detect surface-associated and internal oocyte Gαs was
surprising but not unprecedented. These two antibodies have been
reported to display different effectiveness in immunoﬂuorescent
detection of Gαs in mouse spermatozoa (Baxendale and Fraser,
2003). The Calbiochem antibody that was used to monitor cortical
Gαs (Fig. 5) is directed against a synthetic peptide (RMHLRQYELL) that
corresponds to amino acids at the C-terminus of mammalian Gαs
subunit (Simonds et al., 1989) and shares sequence identity with the
C-terminal peptide sequence reported for Xenopus Gαs (Olate et al.,
1990). The Santa Cruz antibody (K-20) that was used to analyze
internal 45-kDa Gαs (Fig. 6A) is directed against an undisclosed
synthetic 20-amino acid peptide in the N-terminal region between
amino acids 80–130 in the human Gαs sequence that shares greater
than 80% identity with the corresponding Xenopus amino acid
sequence (Santa Cruz, technical support). The identities of the
lower- and higher molecular weight bands in cortical-free extracts
are not known. In humans four types of mRNAs are apparently derived
from a single Gαs gene by alternate splicing of a single pre-mRNA
transcript that yields a 45-kDa short form and a 52-kDa long form of
Gαs (Kosaza et al., 1988). Long and short forms of Gαs are unequally
distributed in different mammalian tissues (for review, see Novotny
and Svoboda, 1998), and biochemical evidence in different animal and
organ systems offers only limited evidence that Gαs variants are
functionally different. Olate et al. (1990) reported the cloned sequence
of a short form of Xenopus Gαs and speculated about the possible
presence of additional subtypes. Detection of a 52-kDa band with the
Santa Cruz anti-Gαs antibody suggests the possible presence of a long
form of Gαs in cortical-free extracts. But, our analysis focused
exclusively on the apparent 45-kDa short form that was detected in
both cortices and cortical-free extracts.
A third antibody (RM anti-Gαs) was used in a ﬁnal set of
experiments to compare decreases in cortical Gαs to increases in
internal Gαs after treatment of oocytes with progesterone in side-by-
side samples on immunoblots. RM anti-Gαs (Gallo et al., 1995) is also
directed against the RMHLRQYELL decapeptide — the same peptide
sequence that was used to generate the Calbiochem antibody. As
shown in Fig. 6B (left panel), RM anti-Gαs detected 45- and 47-kDa
immunoblot bands in both cortices and cortical-free extracts. The 45-
kDa band was the predominant form in cortical samples (Fig. 6B, left,
lane 1), and the 47-kDa band was the primary form in cortical-free
extracts (Fig. 6B, left, lane 2). Cortical samples had to be overloaded or
overexposed to indicate the presence of lesser amounts of the 47-kDa
band (Fig. 6B, left, lane 3). For side-by-side comparison of changes in
levels of 45-kDa Gαs in cortical and internal extracts, gel lanes were
loaded with reduced amounts of total protein (0.5 oocyte equivalents
per lane), and longer ﬁlm exposures were used to generate banding
patterns that could be used to distinguish and measure the densities
of 45-kDa bands. As shown in Fig. 6B (right panel), the relative
amount of 45-kDa Gαs that was lost from the oocyte surface after
progesterone treatment was recovered in equivalent portions of
cortical-free extract.
Possible mechanisms and species comparisons
The mechanisms at work that drive the hormone- or drug-induced
release of Gαs from the oocyte surface are not known. G proteins have
been shown to be speciﬁcally enriched in cholesterol-rich micro-domains surrounding G protein-coupled receptors (GPRs), creating an
organizing arrangement within the plane of the plasma membrane
that supports the interactions of receptors and G proteins (Perez et al.,
2006). In cortices prepared from unstimulated Xenopus oocytes, 45-
kDa Gαs is also contained in low-density, cholesterol-enriched
membrane (Fig. 5). Treatment of oocytes with the cholesterol-
depleting drug, MeβCD, is apparently sufﬁcient to activate the
progesterone-signaling pathway (including phosphorylation of
MAPK (Fig. 1) and synthesis of Mos (Fig. 2) and involves release of
Gαs from the oocyte surface (Fig. 5). But, the mechanism by which
treatment of oocytes with progesterone leads to release of Gαs (Figs. 5
and 6) is not clearly understood.
Since cortical Gαs is contained in cholesterol-rich low-density
membrane and treatment of oocytes with progesterone or choles-
terol-depleting MeβCD leads to decreased surface-association of Gαs
(Fig. 5), cholesterol may stabilize membrane association of Gαs.
Disruption of this cholesterol-stabilizing effect by cholesterol deple-
tion or progesterone action could account for Gαs release, but other
mechanisms may be at work. Activation of Gαs in other cell systems
has been shown to also involve G protein degradation (Levis and
Bourne, 1992; Moravcová et al., 2004). In the experiments that we
report here, changes in total oocyte Gαs were not measured. So, our
results neither support nor refute the possibility of Gαs degradation
in amphibian oocytes after hormone treatment. The relative changes
in cortical and internal levels of Gαs are also confounded by the
observation that levels of internal 47-kDa protein also increased
following progesterone treatment of oocytes (data not shown), and
the combined increase in 45- and 47-kDa Gαs bands was greater than
the apparent amount of 45-kDa Gαs that was released from cortical
membranes. Even though the relationship between the 45- and 47-
kDa bands (Fig. 6B) is not known, if one assumes that the
immunoblot band densities are reﬂective of relative amounts of G
protein, then the measured release of Gαs from the oocyte surface
cannot account for the measured increase in Gαs in cortical-free
extract. Gallo et al. (1995) reported Gαs in cortices and in yolk
platelet membranes, and immunoﬂuorescence data from mammalian
oocytes also suggests an association of Gαs with intracellular
membrane (Freudzon et al., 2005). The increase in internal Gαs in
response to treatment of oocytes with progesterone could be due to
release of G protein from both plasma membrane and internal
membranes. Additional experiments are required to determine if
progesterone might also affect Gαs in yolk platelet membranes. And,
even though we are conﬁdent that the extracts used to track changes
in internal Gαs are cortical-free, it is possible that Gαs could partition
into internal membrane that might remain suspended in low-speed,
cortical-free extracts.
It is not known whether association of Gαs with the oocyte
plasma membrane is due to direct interaction of G protein with
membrane proteins or to preferential partitioning of the G protein
lipid anchors into cholesterol-rich membrane domains. Both Xenopus
Gαs (Olate et al., 1990) and mammalian Gαs (Mumby et al., 1994)
share N-terminal amino acid sequence identity with Cys in the third
position. Cys-3 is the site of palmitoylation in mammalian Gαs
(Mumby et al., 1994), and it is likely that Cys-3 is also palmitoylated
on Xenopus Gαs. N-terminal palmitoylation has been observed to
play a role in activation-induced translocation of Gαs from plasma
membrane to cytosol (Thiyagarajan et al., 2002), and palmitoylation
is also likely to play a role in membrane association of Gαs in Xenopus
oocytes. G protein βγ subunits may also play an important role in the
progesterone-signaling cascade. Lutz et al. (2000) reported that Gβγ
inhibits progesterone-induced signaling and Xenopus oocyte matura-
tion. It will be interesting to learn if dissociation of Gαs from βγ
correlates with and contributes to Gαs internalization.
In both amphibian and mammalian oocytes, the signaling
mechanisms that maintain meiotic arrest and trigger oocyte matura-
tion apparently involve orphan G protein-coupled receptors (GPRs)
206 S.E. Sadler et al. / Developmental Biology 322 (2008) 199–207that function either as constitutive activators of adenylyl cyclase or
respond to as yet unidentiﬁed ligands (Eggerickx et al., 1995). The
orphan Gαs-linked receptor GPR3 maintains meiotic arrest in mouse
oocytes and supports localization of Gαs to the plasma membrane;
oocytes of Gpr3 knockout mice resume LH-independent meiosis in
antral follicles, and injection of Gpr3 RNA reverses the phenotype
(Mehlmann et al., 2004). Moreover, in oocytes of Gpr3-/- mice Gαs is
more strongly localized in the plasma membrane than in Gpr3+/+
mouse oocytes; and, maintenance of prophase arrest depends upon
constitutive activity of GPR3 (Freudzon et al., 2005). GPR12 is involved
in maintenance of meiotic arrest in rat oocytes, and expression of
GPR3 or GPR12 in Xenopus laevis oocytes prevents progesterone-
induced meiotic maturation (Hinckley et al., 2005). So, G protein-
coupled receptors have the capacity to affect Gαs localization in
oocytes and to alter progesterone signaling. Functional and structural
analogies support the existence of a steroid-binding GPR on the
surface of amphibian oocytes, and homologous genes for membrane
progestin receptors have been identiﬁed (Zhu et al., 2003a,b). Maller's
group (Ben-Yehoshua et al., 2007) recently described the putative
membrane progesterone receptor (XmPRβ) in Xenopus oocytes, but
cell signaling mechanisms involving XmPRβ have not been fully
characterized, and receptor-G protein interactions have not yet been
investigated.
The results reported heredemonstrate that treatment of amphibian
oocytes with cholesterol-depleting MeβCD is sufﬁcient to trigger the
progesterone-signaling pathway leading to oocyte maturation (meio-
sis) and that the progesterone response involves release of cortical Gαs.
Translocation of Gαs from the plasmamembranemay be accompanied
by other important molecular events. Expression of mammalian G-
protein-coupled receptorkinase (GRK3) and ratβ-arrestin-2have been
shown to stimulate hormone-independent GVBD (Wang and Liu,
2003); therefore, GPR desensitization and receptor internalization
might accompany release of Gαs. More experimentation is required to
decipher the complexities of molecular events involved in the non-
genomic effects of progesterone at the cell surface, and to determine
whether release of Gαs is a required trigger for the maturation
response, or if it results from membrane remodeling that is a
consequence of other molecular responses that drive progression
toward germinal vesicle breakdown and oocyte maturation.
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